Alterity Therapeutics (ATHE) Operating Leases (2019 - 2025)

Alterity Therapeutics' Operating Leases history runs 7 years deep, the most recent figure standing at $56707.2 for Q2 2025.

• In Q2 2025, Operating Leases rose 65.75% year-over-year to $56707.2; the TTM figure through Jun 2025 stood at $56707.2 (up 65.75% YoY), while the FY2025 annual figure was $56707.2, up 65.75% from the prior year.
• Operating Leases was $56707.2 for Q2 2025 at Alterity Therapeutics, up from $34212.6 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $68979.5 in Q2 2023 to a low of $29187.4 in Q2 2021.
• Historically, Operating Leases has averaged $46392.1 across 5 years, with a median of $42873.7 in 2022.
• The sharpest annual moves came in 2024 and 2025: Operating Leases slumped 50.4% in 2024, then soared 65.75% in 2025.
• A 5-year view of Operating Leases shows it stood at $29187.4 in 2021, then jumped by 46.89% to $42873.7 in 2022, then surged by 60.89% to $68979.5 in 2023, then plunged by 50.4% to $34212.6 in 2024, then jumped by 65.75% to $56707.2 in 2025.
• The last three Operating Leases figures came in at $56707.2 (Q2 2025), $34212.6 (Q2 2024), and $68979.5 (Q2 2023), per Business Quant data.